Air India Grounds All Pilots for Mandatory Drug Tests After Mid-Air Scare

Air India has swiftly implemented a one-time, mandatory drug screening for all its 5,000 pilots, including those from its subsidiary Air India Express, effective August 13, 2026. This unprecedented move comes just days after the pilot-in-command of an Air India Phuket-Delhi flight (AI2379) on August 4 tested positive for marijuana, following a concerning mid-air incident where the aircraft unexpectedly lost 300 feet of altitude, injuring passengers and crew. The airline's decision goes significantly beyond the existing Directorate General of Civil Aviation (DGCA) regulations, which only mandate random drug tests for 10% of flight crew annually. The incident, involving an Airbus A320neo carrying 137 passengers, is currently under investigation by the Aircraft Accident Investigation Bureau (AAIB), focusing on both the pilot's drug test results and potential technical glitches. This latest safety concern adds pressure on Air India, which has been actively working to overhaul its operations and safety image following previous high-profile incidents. Pilots will undergo these critical tests during training sessions, post-flight at briefing centers, or at their designated bases, with the airline emphasizing this initiative is crucial for passenger confidence and upholding the highest safety standards. Meanwhile, the Indian government is reportedly reviewing existing Civil Aviation Requirements to potentially introduce stricter penalties and more frequent drug testing across the aviation sector. The outcome of these broader regulatory discussions and Air India internal screenings will be closely watched by the industry and travelers alike.